Abstracts tagged "pain and pediatric rheumatology"

Abstract Number: 1331 • 2014 ACR/ARHP Annual Meeting
Factors Associated with Pain in Children with Hypermobility – a Pilot Study
Susan Maillard¹, Clarissa Pilkington¹, Richard Howard², Christine Liossi³ and Suellen Walker⁴, ¹Paediatric Rheumatology, Great Ormond Street Hospital NHS Foundation Trust for Children, London, United Kingdom, ²Pain Department, Great Ormond Street Hospital NHS Foundation Trust for Children, London, United Kingdom, ³Pain Service, Great Ormond Street Hospital NHS Foundation Trust for Children, London, United Kingdom, ⁴Pain Department, Great Ormond Street Hospital NHS Foundation Trust for Children, London, United Kingdom
Background/Purpose: To explore the relationships between the degree of musculoskeletal pain, pain associated with disability and quality of life and how they are affected by…
Abstract Number: 2420 • 2012 ACR/ARHP Annual Meeting
Frequent Self-Reported Pain and Disease Symptoms in Juvenile Idiopathic Arthritis Persist Despite Advances in Medication Therapies: An Electronic Diary Study
Maggie H. Bromberg¹, Mark Connelly², Kelly K. Anthony³, Karen M. Gil¹ and Laura E. Schanberg⁴, ¹Psychology, University of North Carolina at Chapel Hill, Chapel Hill, NC, ²Integrative Pain Management, Children's Mercy Hospitals and Clinics, Kansas City, MO, ³Medical Psychology, Duke University Medical Center, Durham, NC, ⁴Pediatrics, Duke University Medical Center, Durham, NC
Background/Purpose: Previous research has demonstrated that children with Juvenile Idiopathic Arthritis (JIA) experience frequent pain that interferes with performing tasks at home and at school.…
Abstract Number: 2030 • 2012 ACR/ARHP Annual Meeting
A Multi-Modal Amplified Musculoskeletal Pain Treatment Program: Associations of Previous Pharmacotherapy with Subsequent Outcomes
Cara M. Hoffart¹, Pamela Weiss², David D. Sherry³, Chris Feudtner⁴ and Margaret Stineman⁵, ¹The Children's Hospital of Philadelphia, Philadelphia, PA, ²Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, ³Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, ⁴Division of General Pediatrics, Children's Hospital of Philadelphia; University of Pennsylvania Center for Clinical Epidemiology and Biostatistics, Philadelphia, PA, ⁵The University of Pennsylvania, Philadelphia, PA
Background/Purpose: Management of Amplified Musculoskeletal Pain (AMP) in children (i.e. juvenile primary fibromyalgia, complex regional pain syndrome, neuropathic pain, central sensitization) remains controversial. Common practice…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].